Kv1.3: A potential pharmacological target for diabetes

Research output: Contribution to journalReview articlepeer-review

Abstract

K+ channels, which are ubiquitous membrane proteins, play a central role in regulating the resting membrane potential and the shape and duration of the action potential in pancreatic Β-cells. There are at least three types of K+ channels (KATP, K Ca, and Kv2.1 channels) that are involved in glucose-stimulated insulin secretion in pancreatic Β-cells, and one type (Kv1.3) that is associated with the regulation of insulin sensitivity in peripheral target tissues. This article reviews the function of Kv1.3 channels that contribute to mediating insulin action in insulin-sensitive tissues. Pharmacological strategies for targeting Kv1.3 are then discussed with a focus on a rationale for the potential therapeutic use of Kv1.3 blocker in diabetic treatment.

Original languageEnglish
Pages (from-to)1031-1035
Number of pages5
JournalActa Pharmacologica Sinica
Volume31
Issue number9
DOIs
StatePublished - 2010.09

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diabetes
  • insulin
  • K channels
  • Kv1.3
  • rosiglitazone

Quacquarelli Symonds(QS) Subject Topics

  • Pharmacy & Pharmacology

Fingerprint

Dive into the research topics of 'Kv1.3: A potential pharmacological target for diabetes'. Together they form a unique fingerprint.

Cite this